Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care

Slide: 17 of 36

Mean Differences in Mortality and Thromboembolic Event Rates by Study and rFVIIa Indication

 

This figure includes indications with two or more comparative studies: intracranial hemorrhage (ICH)*, body trauma (Trauma), brain trauma (TBI), liver transplantation (LvrTx), and adult cardiac surgery (AdCS). Each circle represents a study; larger circles correspond to larger studies; shaded circles represent studies on treatment use of rFVIIa, and white circles represent studies on prophylactic use of rFVIIa. The mean differences in event rates for the direct (patient-centered) outcomes of total mortality and thromboembolic events are plotted for each comparative study and according to each rFVIIa indication using circle charts, with the area of each circle approximating the total sample size of its respective study.

The figures show mean differences in mortality and thromboembolic event rates, respectively, for each comparative study and according to each rFVIIa indication.

*ICH = intracranial hemorrhage here—although in rest of report “ICH” indicates a subset of intracranial hemorrhage, namely intracerebral hemorrhage.